Search research articles
Contact Us
Filters
Showing results (41-50 of 89) with videos related to
Page
of 9
Sort By:
Surgery Today
|
February 1, 2018
Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan
Kouhei Fukushima, Akira Sugita, Kitaro Futami, et al.
Gastro Hep Advances
|
August 12, 2024
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, et al.
Digestion
|
January 17, 2021
Week 2 Symptomatic Response with Vedolizumab as a Predictive Factor in Japanese Anti-TNFα-Naive Patients with Ulcerative Colitis: A post hoc Analysis of a Randomized, Placebo-Controlled Phase 3 Trial
Masakazu Nagahori, Kenji Watanabe, Satoshi Motoya, et al.
BMC Gastroenterology
|
November 23, 2019
Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
Satoshi Motoya, Hiroki Tanaka, Tomoyoshi Shibuya, et al.
Intestinal Research
|
May 14, 2016
Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan
Shunsuke Komoto, Satoshi Motoya, Yuji Nishiwaki, et al.
The Lancet. Gastroenterology & Hepatology
|
April 22, 2021
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
Taku Kobayashi, Satoshi Motoya, Shiro Nakamura, et al.
Crohn'S & Colitis 360
|
May 7, 2024
Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study
Katsuyoshi Ando, Mikihiro Fujiya, Nobuhiro Ueno, et al.
Inflammatory Bowel Diseases
|
October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease
Toshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Journal of Gastroenterology and Hepatology
|
December 21, 2013
Use of capsule endoscopy in patients with Crohn's disease in Japan: a multicenter survey
Motohiro Esaki, Takayuki Matsumoto, Kenji Watanabe, et al.
Intestinal Research
|
March 10, 2022
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 89) with videos related to
Sort By:
Page
of 9
Surgery Today
|
February 1, 2018
Postoperative therapy with infliximab for Crohn's disease: a 2-year prospective randomized multicenter study in Japan
Kouhei Fukushima, Akira Sugita, Kitaro Futami, et al.
Gastro Hep Advances
|
August 12, 2024
Shorter Crohn's Disease Duration Is Associated With Better Clinical and Endoscopic Outcomes With Risankizumab in Phase 3 Studies
Laurent Peyrin-Biroulet, Jean-Frederic Colombel, Edouard Louis, et al.
Digestion
|
January 17, 2021
Week 2 Symptomatic Response with Vedolizumab as a Predictive Factor in Japanese Anti-TNFα-Naive Patients with Ulcerative Colitis: A post hoc Analysis of a Randomized, Placebo-Controlled Phase 3 Trial
Masakazu Nagahori, Kenji Watanabe, Satoshi Motoya, et al.
BMC Gastroenterology
|
November 23, 2019
Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study
Satoshi Motoya, Hiroki Tanaka, Tomoyoshi Shibuya, et al.
Intestinal Research
|
May 14, 2016
Pregnancy outcome in women with inflammatory bowel disease treated with anti-tumor necrosis factor and/or thiopurine therapy: a multicenter study from Japan
Shunsuke Komoto, Satoshi Motoya, Yuji Nishiwaki, et al.
The Lancet. Gastroenterology & Hepatology
|
April 22, 2021
Discontinuation of infliximab in patients with ulcerative colitis in remission (HAYABUSA): a multicentre, open-label, randomised controlled trial
Taku Kobayashi, Satoshi Motoya, Shiro Nakamura, et al.
Crohn'S & Colitis 360
|
May 7, 2024
Effectiveness and Persistency of Ustekinumab Treatment for Ulcerative Colitis: A Phoenix retrospective Cohort Study
Katsuyoshi Ando, Mikihiro Fujiya, Nobuhiro Ueno, et al.
Inflammatory Bowel Diseases
|
October 12, 2011
Retrieval of serum infliximab level by shortening the maintenance infusion interval is correlated with clinical efficacy in Crohn's disease
Toshifumi Hibi, Atsushi Sakuraba, Mamoru Watanabe, et al.
Journal of Gastroenterology and Hepatology
|
December 21, 2013
Use of capsule endoscopy in patients with Crohn's disease in Japan: a multicenter survey
Motohiro Esaki, Takayuki Matsumoto, Kenji Watanabe, et al.
Intestinal Research
|
March 10, 2022
Efficacy and safety of filgotinib as induction and maintenance therapy for Japanese patients with moderately to severely active ulcerative colitis: a post-hoc analysis of the phase 2b/3 SELECTION trial
Toshifumi Hibi, Satoshi Motoya, Tadakazu Hisamatsu, et al.
Page
of 9